Mednax Inc (MD) : The consensus on Mednax Inc (MD) based on 13 analyst recommendation on the company stock is 1.77, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 7 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 4 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Mednax Inc (MD) : The consensus price target for Mednax Inc (MD) is $81.5 for the short term with a standard deviation of $8.09. The most optimist securities analyst among the 10 who monitor the stock believes that the stock can reach $94, however, the pessimist price target for the company is $70.
Mednax Inc (NYSE:MD): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $72.48 and $72.38 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $73.26. The buying momentum continued till the end and the stock did not give up its gains. It closed at $73.21, notching a gain of 0.76% for the day. The total traded volume was 631,344 . The stock had closed at $72.66 on the previous day.
The company shares have dropped -3.54% from its 1 Year high price. On Aug 18, 2015, the shares registered one year high at $86.09 and the one year low was seen on Feb 4, 2016. The 50-Day Moving Average price is $69.27 and the 200 Day Moving Average price is recorded at $67.93.
MEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.